Articles On Telix Pharmaceuticals (ASX:TLX)

In this week's Weekly Insights:-Investing In Non-Profitable Companies-Corporate Updates: Early Signals-Peak Resources?-FNArena TalksBy Rudi Filapek-Vandyck, Editor FNArenaInvesting In Non-Profitable CompaniesThe 2022 patience-testing, volat...

MELBOURNE, Australia, Oct. 20, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended 30 Septem...

A strong lead-in from Wall Street gave solid impetus to the Australian market on Tuesday, and the result was a lift of 114.8 points, or 1.7 per cent, in the benchmark S&P/ASX 200 (INDEXASX: XJO) Index, to 6779.2; while the broader S&amp...

ShareCafeEnergy only sector lagging: ASX closes 1.72% higher by Peter Milios   The ASX has continued rising since lunchtime. At the closing bell, the S&P/ASX 200 was 1.72 per cent or 114.80 points higher at 6779.20. The sector of the da...

ASX regains yesterday’s losses as volatility in the market continues All ASX sectors rose except Energy RBA deputy governor Michelle Bullock says RBA will keep lifting rates   The seesaw game continues as the ASX 200 gained 1.80% on Tuesd...

The S&P/ASX 200 Index (ASX: XJO) jumped higher on Tuesday, driven by tech shares. The index ended the day 1.72% higher at 6,779.2 points. Its strong performance followed Wall Street’s day in the green. The Dow Jones Industrial Averag...

The share market logged its highest close in a week and a half after a UK government backdown on a controversial tax plan helped trigger a massive relief rally on Wall Street. The S&P/ASX 200 jumped 115 points or 1.72 per cent to 677...

The S&P/ASX 200 Index (ASX: XJO) is back on form on Tuesday. In afternoon trade, the benchmark index is up 1.3% to 6,749.4 points. Four ASX shares that are climbing more than most today are listed below. Here’s why they are rising:...

The share market reversed yesterday’s loss after Wall Street welcomed a UK government decision to scrap unfunded tax cuts that sent tremors through financial markets.     The S&P/ASX 200 rallied 93 points or 1.39 per cent by mid-sess...

Telix (ASX:TLX) has announced that Health Canada has approved Illuccix gozetotide injection] for use in staging and re-staging intermediate and high-risk prostate cancer and localising tumour tissue in recurrent prostate cancer....

The S&P/ASX 200 Index (ASX: XJO) started the week out on the wrong foot. It fell 1.4% on Monday to close at 6,664.4 points. It followed a similarly disappointing Friday on Wall Street wherein the Dow Jones Industrial Average Index (DJX...

New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare’s immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials Telix tracers evaluate levels of carbonic anhydrase...

Telix Pharmaceuticals (TLX) has expanded its partnership with GE Healthcare via a deal to supply its investigational positron emission tomography (PET) imaging radiotracersThe company penned the collaborative development and reseller agreem...

Patrys crosses blood brain barrier in health animals Cynata receives Notice of Acceptance from IP Australia Telix announces collaboration with GE Healthcare Patrys (ASX:PAB) surged 15% this morning after announcing that its full-sized deo...

MELBOURNE, Australia, Oct. 17, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approve...

ASX healthcare shares have been a mixed bag in 2022. The industry was flourishing during the later part of the last calendar year but took a turn as early as November. The downside continued along with the broader sell-off in equities....

Highlights The ASX 200 benchmark index closed up today, gaining 116.20 points or 1.75% to end at 6,758.80 points. Over the last five days, the index is virtually unchanged, but is down 9.21% for the last year to date. Energy was the b...

The ASX finished almost 2% higher on Friday, flat for the week UK-exposed stocks rose on potential policy U-turn by PM Liz Truss China’s inflation at 2-year high   The ASX tracked Wall Street higher today as the local index finished the d...

Telix Pharmaceuticals (TLX) gets approval from Health Canada for its imaging agent Illuccix for prostate cancer imagingThe company says Illuccix is the first PSMA PET imaging agent to be granted regulatory approval in Canada and is the thir...

Telix granted approval in Canda EBR Systems halt trading, pending a manufacturing change announcement   Telix Pharma (ASX: TLX) announced that Health Canada has approved lead product Illuccix for use in staging and re-staging prostate can...

The S&P/ASX 200 Index (ASX: XJO) closed in the red after spending most of today in the green. The index ended Thursday’s trade 0.07% lower at 6,642.6 points. Only one of the market’s sectors posted a notable gain today. The S&P/ASX...

During latest period of volatility many health stocks have seen their share prices remain quite stable Several ASX health stocks have rallied this week on positive news including Polynovo on $5 million sales month Telix Pharmaceuticals ral...

Highlights: The S&P/ASX 200 closed significantly up on Wednesday (05 October 2022), gaining 1.74% to 6,815.70 points. Ten out of eleven major sectors ended in green today. Information Technology ended 3.85% higher while the Consum...

The S&P/ASX 200 Index (ASX: XJO) recovered further from its September rout today. The index closed 1.74% higher at 6,815.70 points on Wednesday. It followed a strong session on Wall Street overnight that saw the Dow Jones Industrial Av...

The ASX gains another 1.7% on Wednesday All 11 sectors rose excepts Consumer Discretionary RBNZ raised cash rate by another 50bp   After the 3% surge yesterday, Aussie shares lifted another 1.7% on Wednesday as risk appetite makes its way...

The Imugene Limited (ASX: IMU) share price had a rough month despite multiple clinical trial updates. Imugene shares have fallen 30.77% from 26 cents at market close on 31 August to 18 cents at market close on 30 September....

Telix Pharmaceuticals (ASX: TLX) has announced it has withdrawn its application to market the company’s lead prostate cancer imaging product, Illuccix, in Europe. The Danish Medicines Agency asked for additional chemistry, manufacturing and...

MELBOURNE, Australia, Sept. 30, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose in New Zealand of its prostate cancer imaging agent, Illuccix® (Kit for Preparatio...

Telix Pharmaceuticals (ASX:TLX) and GenesisCare, the largest provider of integrated cancer care in Australia, have announced that a first patient has been enrolled in the Phase 2 ProstACT TARGET study of prostate cancer antibody the...

ShareCafeASX erases yesterday’s gains: Aus shares close 0.5% lower by Lauren Hayes   It was choppy trading on the ASX today with the S&P/ASX 200 commencing the session in positive territory, before slipping into the red for afternoon tr...

Highlights: The ASX 200 benchmark index closed 0.53% lower to end at 6,462.00 points. Over the last five days, the index has lost 3.56% and has shed 11.18% over the last 52 weeks. IT was the worst performing sector, losing 1.61%....

The ASX was down 0.55% on Wednesday AUD drops below US64c RBA tells the ASX to improve its governance   The stock market continues to be volatile as local shares wiped yesterday’s gains to close 0.55% lower on Wednesday. The Tech sector l...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the day deep in the red. At the time of writing, the benchmark index is down 0.75% to 6,447 points. Four ASX shares that are falling more than most today are list...

ShareCafeASX marginally lower: Aus shares down 0.3% at noon By Lauren Hayes   The ASX gave up modest gains in this morning’s trade to dip into the red at lunchtime trading. At noon, the S&P/ASX 200 is 0.32 per cent or 20.70 points lower...

Telix Pharmaceuticals (TLX) has withdrawn its application to market its Illuccix product in EuropeThis comes after the Danish Medicines Agency requested additional data that Telix said it couldn’t deliver within the prescribed review timefr...

Highlights The Australian shares opened higher on Wednesday. The ASX 200 index opened 14.40 points, or 0.22% higher at 6,510.60. The benchmark has shed 2.83% in past five days. The Australian shares opened higher on We...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking a tumble on Wednesday. In morning trade, the therapeutic radiopharmaceuticals company’s shares are down 12% to $4.74. Why is the Telix share price sinking? Investors have been...

MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approv...

MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose in Australia of its prostate cancer imaging agent, Illuccix® (Kit for Preparation of...

ShareCafeLunch Report: 27 September, 2022 by Lauren Hayes   The ASX is trading higher this morning despite the Dow Jones index entering a bear market overnight, and the British pound having fallen to a record low against the greenback as in...

MELBOURNE, Australia, Sept. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and GenesisCare, the largest provider of integrated cancer care in Australia, today announce that a first patient has been e...

Telix Pharma releases positive study results for TLX101 Imugene doses first patient in Phase 1 clinical trial Final IPAX-1 study data has confirmed the safety and tolerability profile for TLX101, according to Telix Pharma (ASX:TLX). The s...

MELBOURNE, Australia, Sept. 21, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports the final results from the IPAX-1 Ph I/II study of TLX101 therapy (4-L-[ 131I] iodo-phenylalanine, or 131I-IPA...

While there are many successful companies on the ASX that solely serve Australian consumers, there are huge markets to be conquered beyond the seas that girt this land. Expanding internationally is difficult to execute but the end result o...

ShareCafeEvening Report: 20 September, 2022 by Paul Sanger   Australian shares posted solid gains, after Wall Street recovered from its two-day losing streak as investors wait to see how aggressively the US Federal Reserve will lift interes...

Highlights The ASX 200 benchmark index closed up today, gaining 1.29% to end at 6,806.40 points. Over the last five days, the index has lost 2.90% and has shed off 6.10% over the last 52 weeks. Materials was the best performing sector...

Aussie shares caught an up-lift from a general improvement in market mood as investors prepare for a jumbo US rate hike and embrace the possibility of smaller increases in Australia. The S&P/ASX 200 bounced 86.5 points or 1.29 per ce...

Australian home and business owners are now paying back more than two more percentage points in interest than they were just four months ago. The Reserve Bank of Australia is deliberately trying to slow the economy to bring inflation under...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

The S&P/ASX 200 Index (ASX: XJO) broke a two-session losing streak on Wednesday as energy shares bolstered the market. The index closed 0.52% higher at 6,998.10 points. The S&P/ASX 200 Energy Index (ASX: XEJ) led the way on Wednesd...